p53 is inactivated in melanoma through mutations and copy number losses [41,42,43,44], deletions of CDKN2A [41,42,43,44], or amplifications of MDM2 [45,46], all of which could lead to a reduction in miR-29b2~c expression. Here, CDKN2A is linked to melanoma.